Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women

The objective of this study is to compare the curative effects in patients under the age of 35 with hormone receptor positive breast cancer and high recurrent risk factors including large tumor or metastatic lymph nodes randomized to ovarian function suppression (OFS) plus aromatase inhibitors or OFS plus tamoxifen as …

aromatase inhibitor
tamoxifen
adjuvant chemotherapy
immunohistochemistry
invasive breast cancer
  • 8 views
  • 21 Jan, 2021
  • 12 locations
PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

In ER+ and HER2- breast cancer(BC) patients for whom BCS is not feasible, we investigate the rate of BCS can be increased while decreasing unnecessary chemotherapy thru selective neoadjuvant chemotherapy or neoadjuvant endocrine therapy using tools of nodal status, Ki-67, and multigene assay(Mammaprint)

letrozole
breast-conserving surgery
her2/neu-negative breast cancer
HER2
ki-67
  • 0 views
  • 21 Mar, 2021
  • 1 location